Patient indicators of a pulmonary exacerbation: Preliminary reports from school aged children map onto those of adults

Journal of Cystic Fibrosis

Volumn 11, Issue 3, 2012, Pages 180-186

  Abbott, J ^a   Holt, A ^a   Morton, A M ^b   Hart, A ^c   Milne, G ^d   Wolfe, S P ^e   Conway, S P ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

^d NINEWELLS HOSPITAL   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Patient reported outcome; Pulmonary exacerbation; Respiratory symptoms

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; PRESCHOOL CHILD; SCHOOL CHILD; SELF REPORT; SPUTUM EXAMINATION; STANDARDIZATION; SYMPTOM; THEMATIC ANALYSIS;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; QUESTIONNAIRES; SCHOOLS; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 84860622640     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.11.005     Document Type: Article

References (29)

1. Britto M.T., Kotagal U.R., Hornung R.W., Atherton H.D., Tsevat J., Wilmott R.W. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002, 121:64-72.
2. Goldbeck L., Zerrer S., Schmitz T.G. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros 2007, 6:171-178.
3. Smyth A., Elborn J.S. Exacerbations in cystic fibrosis: 3 - management. Thorax 2008, 63:180-184.
4. Liou T.G., Adler F.R., FitzSimmons S.C., Cahill B.C., Hibbs J.R., Marshall B.C. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153:345-352.
5. Ellaffi M., Vinsonneau C., Coste J., Hubert D., Burgel P.R., Dhainaut J.F., et al. One year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:158-164.
6. Dakin C., Henry R., Field P., Morton J. Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol 2001, 31:436-442.
7. Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999, 340:23-30.
8. Fuchs H.J., Borowitz D.S., Christiansen D.H., Morris E.M., Nash M.L., Ramsey B.W., et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994, 331:637-642.
9. Rosenfeld M., Emerson J., Williams-Warren J., Pepe M., Smith A., Montgomery A.B., et al. Defining a pulmonary exacerbation in cystic fibrosis. Pediatr Pulmonol 2001, 139:359-365.
10. Rabin H.R., Butler S.M., Wohl M.E., Geller D.E., Colin A.A., Schidlow D.V., et al. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004, 37:400-406.
11. Piedra P.A., Grace S., Jewell A., Spinelli S., Bunting D., Hogerman D.A., et al. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J 1996, 15:23-31.
12. Kanga J., Kuhn R., Craigmyle L., Haverstock D., Church D. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther 1999, 21:1343-1356.
13. Hafen G.M., Ranganathan S.C., Robertson C.F., Robinson P.J. Clinical scoring systems in cystic fibrosis. Pediatr Pulmonol 2006, 41:602-617.
14. Goss C.H., Burns J.L. Exacerbations in cystic fibrosis 1: epidemiology and pathogenesis. Thorax 2007, 62:360-367.
15. Gee L., Abbott J., Conway S., Etherington C., Webb A.K. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000, 55:946-954.
16. Goldbeck L., Schmitz T., Henrich G., Herschbach P. Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest 2003, 123:42-48.
17. Modi A.C., Quittner A.L. Validation of a disease specific measure of health related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003, 28. 535-346.
18. Quittner A., Buu A., Messer M., Modi A., Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005, 128:2347-2354.
19. Baars R.M., Atherton C.I., Koopman H.M., Bullinger M., Power M. The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes 2005, 3:70. the DISABKIDS group.
20. Goss C.H., Edwards T.C., Ramsey B.W., Aitken M.L., Patrick D.L. Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros 2009, 8:245-252.
21. Abbott J., Holt A., Hart A., Morton A.M., MacDougall L., Pogson M., et al. What defines a pulmonary exacerbation? Perceptions of adults with cystic fibrosis. J Cyst Fibros 2009, 8:356-359.
22. Smith J.A. Reflecting on the development of interpretive phenomenological analysis and its contribution to qualitative research in psychology. Qual Res Psychol 2004, 1:39-54.
23. Wainwright S. Analysing data using grounded theory. Nurse Res 1994, 3:43-46.
24. Strauss A., Corbin J. Basics of qualitative research: grounded theory procedures and techniques 1990, Sage, Newbury Park C.A.
25. Glaser B. Theoretical sensitivity 1978, Advances Sociology Press, Mill Valley, California.
26. Knudson R.J., Lebowitz M.D., Holberg C.F., Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983, 127:725-734.
27. Subbarao P., Lebecque P., Corey M., Coates A.L. Comparison of spirometric reference values. Pediatr Pulmonol 2004, 36:515-522.
28. Kulich M., Rosenfield M., Campbell J., Kronmal R., Gibson R.L., Goss C.H., et al. Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005, 172:885-891.
29. Abbott J., Hart A., Morton A.M., Dey P., Conway S.P., Webb A.K. Can health-related quality of life predict survival in adults with cystic fibrosis?. Am J Respir Crit Care Med 2009, 17:954-958.